Develops point-of-care testing platforms for pharmacies to screen for diseases like diabetes and heart disease.
Dec 2024Revenue C$4.66M/yrExpenses C$4.53M/yr
Reached break-even Nov 2024
Figures by year
When did Avricore Health become profitable?
Its revenue passed its expenses in Nov 2024. In the 12 months to Dec 2024, revenue was C$4.66M and expenses C$4.53M.
| Fiscal year to | Revenue | Expenses | Pre-tax profit |
|---|---|---|---|
| Dec 2024 | C$4.66M | C$4.53M | C$129K |
| Dec 2023 | C$3.48M | C$4.18M | −C$693K |
| Dec 2022 | C$1.77M | C$2.59M | −C$818K |
| Dec 2021 | C$123K | C$1.87M | −C$1.75M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.